PropertyValue
?:abstract
  • The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant morbidity and mortality Current therapeutic strategies for COVID-19 have failed to effectively reduce mortality rate, especially for elderly patients A newly developed vaccine against SARS-Cov-2 has been reported to induce the production of neutralizing antibodies in young volunteers However, the vaccine has shown limited benefit in the elderly, suggesting an age-dependent immune response As a result, exploring new applications of existing medications could potentially provide valuable treatments for COVID-19 N-acetylcysteine (NAC) has been used in clinical practice to treat critically ill septic patients, and more recently for COVID-19 patients NAC has antioxidant, anti-inflammatory and immune-modulating characteristics that may prove beneficial in the treatment and prevention of SARS-Cov-2 This review offers a thorough analysis of NAC and discusses its potential use for treatment of COVID-19
is ?:annotates of
?:creator
?:journal
  • Therapeutics_&_Clinical_Risk_Management
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • N-Acetylcysteine to Combat COVID-19: An Evidence Review
?:type
?:who_covidence_id
  • #921106
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ut2g1u2r>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ut2g1u2r>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all